Sulfacytine
Chemical compound
![]() | |
Clinical data | |
---|---|
Other names | 1-ethyl N4-sulfanilylcytosin, 1-ethyl-N-sulfanilylcytosine, N-sulfanilyl-l-ethylcytosine, Sulfacitina [inn-spanish], Sulfacitinum [inn-latin] |
Routes of administration | Oral |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
PubChem SID |
|
DrugBank |
|
ChemSpider |
|
UNII |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C12H14N4O3S |
Molar mass | 294.33 g·mol−1 |
3D model (JSmol) |
|
| |
InChI
|
Sulfacytine is a short-acting sulfonamide antibiotic, taken orally for treatment against bacterial infections. Sulfonamides, as a group of antibiotics, work by inhibiting the bacterial synthesis of folate.[1] In 2006 the drug was discontinued[2][3]
References
- ^ DrugBank DB01298
- ^ Federal Register Section: Food and Drug Administration [Docket No. 2006N–0222] Merck & Co., Inc., et al.; Withdrawal of Approval of 65 New Drug Applications and 52 Abbreviated New Drug Applications] Vol. 71, No. 116 / Friday, June 16, 2006. p34941
- ^ FDA Orange book. Sulfacytine Page accessed May 12, 2015
- v
- t
- e